omniture

Emerald Dairy, Inc. Reports Record Revenue for the Third Quarter 2010

2010-11-16 22:16 1000

New Hailun Facility Begins Production on 10,000-ton Infant Formula Production Line in November

Company Launches Xinganling® Organic Label and Product Line

HARBIN, China, Nov. 16, 2010 /PRNewswire-Asia-FirstCall/ -- Emerald Dairy, Inc. (OTC Bulleting Board: EMDY) ("Emerald Dairy" or "the Company") a leading producer and distributor of infant and children's formula products, today announced financial results for its third quarter ended September 30, 2010.

   Third Quarter 2010 Highlights

  • Revenue was $12.9 million, up 27.0% from 3Q2009 and a quarterly record
  • Gross margins increased 510 basis points to 50.3% driven by higher sales of the Company's high-margin Xinganling(R) brand
  • Adjusted net income was 2.0 million and adjusted EPS was 0.06, an increase of 127% and 100% respectively
  • $7.2 million in cash flow from operations for the first nine months of 2010

Third Quarter 2010 Results

 

3Q 2010

3Q 2009

CHANGE

 

Net Sales

$ 12.9 million

$ 10.2 million

27.0%

 

Gross Profit

$ 6.5 million

$4.6 million

41.4%

 

GAAP Net Income

$ 1.5 million

$ 0.9 million

66.4%

 

EPS (Diluted)

$0.04

$0.03

50.9%

 

Adjusted Net Income*

$ 2.0 million

$ 0.9 million

127.3%

 

Adjusted EPS*

$0.06

$0.03

100.0%

 

* Adjusted Net Income' and 'Adjusted EPS' and non-GAAP calculations and excludes the non-cash charge of $0.1 million related to stock options granted to employees as of September 30, 2010, $0.1 related to the fair value of warrants  issued to consultants amortized during the period and $0.3 related to the fair value of warrants issued for loan costs amortized during the period.

 
       


"We had a very productive third quarter on several fronts," stated Yong Shan Yang, CEO and President of Emerald Dairy, "Xinganling® continues to demonstrate increasing market preference among consumers and families who are willing to  pay a bit more to buy Xinganling versus local and lower end brands.     We continued to make adjustment in our current 9,000 ton capacity line and increased our production for the quarter to meet at least part of this demand.  Beginning November, we brought on line our second production line (line "B") at our new facility in Hailun and we have already begun shipping out orders of Xinganling to our customer base. The expanded capacity will allow us to meet incremental customer demand for our products in 'Tier Two' to 'Tier Four' cities which is are showing increasing appetite for mid-range infant formula products like our Xinganling® -branded products.   Our initial target is to reach forty percent capacity utilization over the next six months and near full capacity within 12 months which should meet forecasted demand with our installed customer base. We are pleased with the returns we have seen with our brand and marketing investments to date as evidenced by growth in our key product lines.  We started selling three organic products under our Xinganling(R) brand and will leverage our broad distribution footprint to gain additional market share," Yang concluded.

Third Quarter 2010 Review

Total revenue for the third quarter of 2010 ended September 30, 2010 was $12.9 million, up 27.0% from $10.2 million for the quarter ended September 30, 2009, which was driven by a 344 metric ton increase in production and shipments of Emerald Dairy products in the quarter. Sales of its mid- and high end price point Xinganling®-branded products increased by24.5% over the year ago period and represented 86.2% of third quarter sales. The Company was also able to further maximize production output in on its current 9,000 ton line to produce and ship more of Emerald Dairy's Xinganling product line.   Another contributor to its revenues was higher pricing on some of the Company's subcontracting production runs, leading to sales increasing by 63.4% to $1.1 million in that business segment during the third quarter.

Gross profit for the third quarter of 2010 was $6.5 million, a 41.4% increase from $4.6 million in the third quarter of 2009.  Overall gross profit margin expanded 510 basis points to 50.3% in the third quarter, with margins up in every product category compared to the same period last year.   Xinganling® increased sales volume and margins contributed the most to gross profits and overall gross profit margins for the quarter.  On average, gross margins for Emerald Dairy core products are detailed below.

Xinangling® Milk Powders – 45%-55% margins

Rice Powders (for lactose intolerance) – 60%-68% margins

Soybean Powders (for lactose intolerance)   - 20%-30% margins

Private Label Contracting - ~10%

Operating expenses for the quarter were $4.1 million, an increase of 19.4%, and were attributed to higher advertising and marketing promotion expenses, in addition to investments to increase the Company's sales force.  Operating income totaled $2.4 million in the third quarter of 2010, a 103.7% increase from $1.2 million in the third quarter of the previous year. Adjusted operating income excluding non-cash items was $3.0 million. The Company's adjusted operating margin was 23.6% compared to 11.8% in the third quarter of the prior year, a 1,180 basis point improvement.

GAAP net income for the third quarter of 2010 was $1.5 million, an increase of 66.4% from $0.9 million in the third quarter of 2009. Earnings per share were $0.04 per diluted share in the quarter. Adjusted net income excluding the non-cash value of stock options and warrants expensed was $2.0 million, an increase of 127.3% year over year. Adjusted earnings per share increased 100.0% to $0.06 based on 34.5 million weighted average diluted shares outstanding on September 30, 2010, compared to 30.8 million fully diluted shares in the year ago period.

Nine Months Results

 

YTD 2010

YTD 2009

CHANGE

 

Net Sales

$ 40.5 million

$ 31.3 million

29.4%

 

Gross Profit

$ 20.1 million

$14.2 million

41.5%

 

GAAP Net Income

$ 0.5 million

$ 3.7 million

-87.6%

 

EPS (Diluted)

$0.01

$0.12

-88.9%

 

Adjusted Net Income*

$7.1 million

$ 3.7 million

91.9%

 

Adjusted EPS*

$0.21

$0.12

72.9%

 

* 'Adjusted Net Income' and 'Adjusted EPS' are non-GAAP calculations and excludes $5 million in non-cash liquidating damages during the nine months ended September 30, 2010, as a result of the extension of warrants previously issued by Company to satisfy certain registration provisions.

Adjusted net income and EPS also excludes the non-cash charge of $0.7 million related to stock options granted to employees as of September 30th, 2010; $0.1 million related to the fair value of warrants issued to consultants amortized during the nine months ended September 30, 2010 and $0.8 related to the fair value of warrants issued for loan costs amortized during the nine months ended September 30, 2010. Adjusted net income and EPS in YTD 2010 exclude the total amount of $6.6 million in non-cash items.

 
       


Revenue for the first nine months of 2010 was $40.5 million, up 29.4% from $31.3 million in the prior year's period, as contribution from each category remained consistent.  Milk powders accounted for 86.6% of revenues, private labeling sales accounted for 7.6% of revenues, rice powder accounted for 3.1% of revenues while soybean powder accounted for 2.7% of revenues for the first nine months of 2010.

Gross profits were $20.1 million, an increase of 41.5% for the period.  Gross profit margin increased by 420 basis points to 49.7% in the first nine months ended September 30, 2010.

Operating expenses grew by 78.3% in the first nine months of 2010 to $17.1 million. Advertising expenses increased by 81.4% to $0.4 million and promotion expenses increased by 64.6% to $0.8 million due to a focus on brand building and marketing.    The Company also coordinated direct marketing programs and introductory promotions to new mothers events with the Company's distributors and retail partners.  

The Company recorded four non-cash charges in the first nine months of 2010;  (i) $5.0 million in liquidated damages as a result of the extension of warrants previously issued by the Company to satisfy certain registration rights provisions (ii) $0.7 million in non-cash stock options for employees (iii) $0.1 million related to the fair value of warrants issued to consultants amortized during the nine months ended September 30, 2010 and (iv) $0.8 related to the fair value of warrants issued for loan costs amortized during the nine months ended September 30, 2010. Excluding these non-cash expenses of approximately $6.6 million, total operating expenses were $10.5 million in the first nine months of 2010 compared to $9.6 million in the first nine months of 2010.

Operating income for the first nine months of 2010 was down 34.7% year-over-year to $3.0 million. Adjusted operating income, excluding $6.6 million of non-cash expenses, was $9.6 million in the first nine months of 2010 compared to $4.6 million in the first nine months of 2009, a 109% increase year over year.

US GAAP net income for the first nine months of fiscal year 2010 was $0.5 million, compared to $3.7 million in the prior year's corresponding period, an 87.6% decrease year over year. Adjusted net income for the first nine months of 2010, which excludes the $6.6 in non-cash expenses was $7.1 million, an increase of 91.9% year over year. Adjusted earnings per share were $0.21 vs. $0.12 in the year ago period, based on 34.1 million and $30.4 million diluted shares outstanding for each respective period.

Financial Condition

As of September 30, 2010, the Company had $14.6 million in cash and equivalents; working capital was $24.4 million, up from $17.3 million as of December 31, 2009; accounts receivable were $6.6 million, compared to $7.2 million as of December 31, 2009; cash flow from operations for the first nine months of 2010 was $7.2 million, compared to $2.1 million for the year ago period due to higher net income and improvements in accounts working capital. The Company had $5.8 million in short term loans as of September 30, 2010. Shareholder's equity was $43.7 million, a 34.0 % increase from $33.4 million reported on December 31, 2009.

Guidance for 2010

Emerald Dairy reiterated its full year 2010 guidance of $60-65 million in revenues and $8.0 to $9.0 in non-GAAP adjusted net income.

Third Quarter 2010 Conference Call

To attend the call, please use the dial-in information below. When prompted, ask for the "Emerald Dairy Call" and/or be prepared to provide the conference ID.


 

    Conference Call Date:          

Tuesday, November 16, 2010

 

    Time:                          

11:00 a.m. Eastern

 

    Conference Line Dial-In (U.S.):

1-877-941-1427

 

    International Dial-In:        

1-480-629-9664

 

    Conference ID:                  

4385521

 

    Webcast link:                  

http://viavid.net/dce.aspx?sid=00007E2E

 

 
   


Please dial in at least 10 minutes before the call to ensure timely participation. A playback will be available through November 23, 2010. To listen, please call 1-877-870-5176 within the United States or 1-858-384-5517 if calling internationally. Utilize the pass code 4385521 for the replay.

This call is being webcast by ViaVid Broadcasting and can be accessed by clicking on this link, http://viavid.net/dce.aspx?sid=00007E2E or at ViaVid's website at http://www.viavid.net , where the webcast can be accessed through November 17, 2011.

About Emerald Dairy

Through its wholly-owned operating subsidiaries, Emerald Dairy, Inc. is a producer and distributor of infant and children's formula, milk powder and soybean products in the People's Republic of China. The Company's products are sold under two brand names -- "Xing An Ling," designed for middle and high-end customers, and "Yi Bai," designed for low-end customers. Emerald Dairy's products are distributed throughout 20 provinces in mainland China and sold in over 6,000 retail points. For further information about Emerald Dairy Inc., please visit the Company's website at http://www.emeralddairy.com/

About Non-GAAP Financial Measures

To supplement the Company's consolidated financial statements, which statements are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures: non-GAAP adjusted net income, and non-GAAP adjusted EPS. The presentation of this financial information is not intended to be considered in isolation or as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. The Company uses these non-GAAP financial measures for financial and operational decision making and as a means to evaluate period-to-period comparisons. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding the Company's performance and liquidity by excluding certain expenses and expenditures that may not be indicative of "recurring core business operating results", meaning operating performance excluding non-cash amortization charges for intangibles. The Company believes that both management and investors benefit from referring to these non-GAAP financial measures in assessing performance and when planning, forecasting and analyzing future periods. These non-GAAP financial measures also facilitate management's internal comparisons to historical performance and liquidity as well as comparisons to competitors' operating results. The Company believes these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of the business.

Forward-Looking Statements

This press release contains certain "forward-looking statements" that involve a number of risks and uncertainties. There can be no assurance that such statements will prove to be accurate and the actual results and future events could differ materially from management's current expectations. Such factors include, but are not limited to, the Company's ability to obtain the necessary financing to continue and expand operations, to market its products in new markets and to offer products at competitive pricing, to attract and retain management, and to integrate and maintain technical information and management information systems, political and economic factors in the PRC, compliance requirement of laws and regulations of the PRC, the effects of currency policies and fluctuations, general economic conditions and other factors detailed from time to time in the Company's filings with the United States Securities and Exchange Commission and other regulatory authorities. The Company undertakes no obligation to publicly update or revise any forward- looking statements, whether as a result of new information, future events or otherwise.

EMERALD DAIRY INC

CONSOLIDATED INCOME STATEMENT


 











 




Three months ended


Nine months ended

 




September 30,


September 30,


September 30,


September 30,

 




2010


2009


2010


2009

 











 

Sales



$     12,897,019


$     10,158,004


$     40,459,377


$     31,261,491

 











 

Cost of Goods Sold

6,408,452


5,569,598


20,356,931


17,057,583

 











 

Gross Profit

6,488,567


4,588,406


20,102,446


14,203,908

 








 

Operating Expenses








 

Selling expenses and administrative expenses

3,999,971


3,348,522


11,906,641


9,448,920

 

Liquidated damages





5,021,669



 

Depreciation and amortization

51,404


43,595


154,356


130,107

 

       Total operating expenses

4,051,375


3,392,117


17,082,666


9,579,027

 




2,437,192


1,196,289


3,019,780


4,624,881

 

Other Income (Expense)

18.9%


11.8%


19.9%


14.8%

 

Interest income

1,418


1,277


3,553


4,421

 

Interest expense

(555,257)


(67,887)


(1,339,936)


(67,887)

 

     Total other income (expense)

(553,839)


(66,610)


(1,336,383)


(63,466)

 











 

Net Income Before Provision for Income Tax

1,883,353


1,129,679


1,683,397


4,561,415

 











 

Provision for Income Taxes








 

Current

411,266


245,054


1,224,008


860,948

 




411,266


245,054


1,224,008


860,948

 











 

Net Income

$       1,472,087


$          884,625


$          459,389


$       3,700,467

 











 

Basic Earnings Per Share

$                0.04


$                0.03


$                0.01


$                0.12

 











 

Basic Weighted  Average Shares Outstanding

34,020,324


30,844,547


33,643,729


29,979,356

 











 

Diluted Earnings Per Share

$                0.04


$                0.03


$                0.01


$                0.12

 











 

Diluted Weighted  Average Shares Outstanding

34,464,712


31,631,381


34,132,311


30,429,024

 











 











 

The Components of Other Comprehensive Income (Loss)








 

Net Income

$       1,472,087


$          884,625


$          459,389


$       3,700,467

 

Foreign currency translation adjustment

977,589


24,487


1,431,900


(14,933)

 

Income tax related to other comprehensive income

(332,380)


(8,326)


(486,846)


5,077

 











 

Comprehensive Income

$       2,117,296


$          900,786


$       1,404,443


$       3,690,611

 

 
                     



EMERALD DAIRY INC

CONSOLIDATED BALANCE SHEETS


 



 

                      ASSETS

 

September 30,


December 31,

 

2010


2009

 

(Unaudited)



 







 

Current Assets




 

Cash and cash equivalents

$       14,559,414


$      13,486,429

 

Trade accounts receivable, net

6,567,168


7,223,016

 

Inventory, net

1,624,509


1,298,488

 

Advances to equipment supplier

10,033,849


3,710,707

 

Other current assets

2,914,909


1,292,749

 

      Total current assets

         35,699,849


        27,011,389

 







 

Property, plant and equipment




 

Property, plant and equipment, net

5,759,821


5,946,330

 

Construction in progress

14,900,348


          8,772,931

 




20,660,169


14,719,261

 







 

Intangible assets, net

1,339,817


1,341,534

 







 




$       57,699,835


$      43,072,184

 







 

                       LIABILITIES AND STOCKHOLDERS' EQUITY

 







 

Current Liabilities




 

Accounts payable and accrued expenses

$         3,750,273


$        2,917,798

 

Notes payable, net of debt discount of $171,755 and $729,830 at September 30, 2010 and December 31, 2009, respectively

           5,844,656


          5,843,472

 

Other current liabilities

391,337


             704,056

 

Current portion of long-term lease

1,080,770


                      -  

 

Loan from shareholder

214,397


210,142

 

     Total current liabilities

         11,281,433


          9,675,468

 







 

Long-term lease payable

           2,754,828


                      -  

 







 

Commitments and Contingencies (Note 19)




 







 

Stockholders' Equity




 

Preferred stock ($0.001 par value, 10,000,000 shares authorized, none issued and outstanding at September 30, 2010 and December 31, 2009)

                        -  


                      -  

 

Common stock ($0.001 par value, 100,000,000 shares authorized, 35,976,575 and 34,890,267 issued and outstanding at September 30, 2010 and December 31, 2009, respectively)

35,977


34,890

 

Treasury Stock (1,944,444 shares at September 30, 2010 and December 31, 2009, respectively)

                (1,944)


               (1,944)

 

Additional paid-in capital

25,862,219


17,003,093

 

Retained earnings (of which $3,191,614 and $1,834,742 are restricted at September 30, 2010 and December 31, 2009, respectively, for common welfare reserves)

14,777,814


14,318,425

 

Accumulated other comprehensive income

2,989,508


2,042,252

 

    Total stockholders' equity

43,663,574


33,396,716

 







 




$       57,699,835


$      43,072,184

 
             



EMERALD DAIRY INC

CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED SEPTEMBER 30


 

 



2010


2009

 






 






 

Cash flows from operating activities




 

Net Income (Loss)

$                459,389


$         3,700,467

 

Adjustments to reconcile net cash provided by




 


operating activities




 


Depreciation and amortization

415,021


400,227

 


Amortization of loan discount

558,075


65,916

 


Capitalized interest

(763,495)


(351,071)

 


Stock issued for services

34,657


33,475

 


Warrants modified for liquidated damages

5,021,669


-

 


Warrants modified for services

-


3,975

 


Warrants issued for services

915,097


-

 


Warrants issued for loan costs

79,991


117,155

 


Incentive stock options

385,891


125,452

 

Net change in assets and liabilities




 


Trade accounts receivable

799,208


(559,266)

 


Inventory

(300,249)


(837,027)

 


Other current assets

(1,112,306)


140,875

 


Accounts payable and accrued expenses

1,024,764


(424,925)

 


Other current liabilities

(326,693)


(313,945)

 






 

Net cash provided by operating activities

7,191,019


2,101,308

 






 

Cash flows from investing activities




 

Deposit on equipment and construction

(6,733,689)


-

 

Construction in progress

(5,189,800)


-

 

Purchases of fixed assets and intangibles

(82,097)


(4,194,717)

 






 

Net cash used in investing activities

(12,005,586)


(4,194,717)

 






 

Cash flows from financing activities




 

Advances on notes payable

800,000


-

 

Repayments of notes payable

(477,464)


-

 

Advances on sale-leaseback

5,090,026


-

 

Repayments of sale-leaseback

(257,555)


-

 

Exercise of warrants

296,408


4,433,590

 






 

Net cash provided by financing activities

5,451,415


4,433,590

 






 

Effect of exchange rate

436,137


(2,762)

 






 

Net decrease in cash

1,072,985


2,337,419

 






 

Cash and cash equivalents at beginning of period

13,486,429


7,343,588

 






 

Cash and cash equivalents at end of period

$           14,559,414


$         9,681,007

 
           



   For more information, please contact:

 

 

   COMPANY:

 

    Mr. Shu Kaneko, CFO

 

    Emerald Dairy Inc.

 

    Email: shu.kaneko@amnutriadairy.com

 

    Web:   http://www.emeralddairy.com/

 

 

   INVESTOR RELATIONS:

 

    John Mattio, SVP

 

    HC International, Inc.

 

    Tel: US +1-203-616-5144

 

    Email:  john.mattio@hcinternational.net

 

    Web:    http://www.hcinternational.net

 
 
Source: Emerald Dairy, Inc.
Related Stocks:
OTC:EMDY
Keywords: Food/Beverages
collection